High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples